Dna X (SONM) Non-Current Receivables (2022 - 2023)
Dna X (SONM) has disclosed Non-Current Receivables for 2 consecutive years, with $7.9 million as the latest value for Q3 2023.
- For the quarter ending Q3 2023, Non-Current Receivables changed N/A year-over-year to $7.9 million, compared with a TTM value of $7.9 million through Sep 2023, changed N/A, and an annual FY2022 reading of $6.8 million, changed N/A over the prior year.
- Non-Current Receivables was $7.9 million for Q3 2023 at Dna X, up from $7.0 million in the prior quarter.
- Across five years, Non-Current Receivables topped out at $7.9 million in Q3 2023 and bottomed at $6.8 million in Q4 2022.